Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:05:11 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



Z:MNK - MALLINCKRODT PLC - http://www.mallinckrodt.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MNK - ZHALTED0.3402    18.10  0.30Aug 25-23Jun 1815 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-06-18 06:48U:MNKNews ReleaseMallinckrodt Announces Publication of Real-World Insights on Patient Experience with Acthar(TM) Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector
2025-06-09 08:30U:MNKNews ReleaseMallinckrodt, Endo Announce Planned Leadership Team for Merged Company
2025-05-14 06:52U:MNKNews ReleaseMallinckrodt Presents Data on Real-World Outcomes with Acthar(TM) Gel (repository corticotropin injection) at the International Congress on Systemic Lupus Erythematosus (LUPUS 2025)
2025-05-13 08:00U:MNKNews ReleaseMallinckrodt and Endo Announce Significant Progress in Proposed Merger
2025-05-06 06:45U:MNKNews ReleaseMallinckrodt plc Reports First Quarter 2025 Financial Results and Reaffirms Full-Year Guidance
2025-04-23 06:52U:MNKNews ReleaseMallinckrodt to Present Data on TERLIVAZ(TM) (terlipressin) for Injection at the 2025 Digestive Disease Week (DDW) Annual Meeting
2025-04-10 06:45U:MNKNews ReleaseMallinckrodt plc to Report Earnings Results for First Quarter 2025
2025-03-13 06:31U:MNKNews ReleaseMallinckrodt plc Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides 2025 Guidance
2025-03-13 06:30U:MNKNews ReleaseMallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
2025-03-10 16:30U:MNKNews ReleaseMallinckrodt plc Reschedules Release of Fourth Quarter and Fiscal Year 2024 Financial Results to Thursday, March 13, 2025
2025-02-27 13:00U:MNKNews ReleaseMallinckrodt plc to Report Fourth Quarter and Fiscal Year 2024 Financial Results
2024-12-02 06:45U:MNKNews ReleaseMallinckrodt Completes Divestiture of Therakos(TM) Business
2024-11-18 11:00U:MNKNews ReleaseMallinckrodt Presents Data on TERLIVAZ(TM) (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting
2024-11-14 09:05U:MNKNews ReleaseMallinckrodt to Present at Jefferies London Healthcare Conference
2024-11-05 06:45U:MNKNews ReleaseMallinckrodt plc Reports Third Quarter 2024 Financial Results and Raises Full Year Guidance
2024-10-30 06:50U:MNKNews ReleaseMallinckrodt to Present Data on TERLIVAZ(TM) (terlipressin) for Injection at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting
2024-10-29 08:30U:MNKNews ReleaseMallinckrodt Presents Data on TERLIVAZ(TM) (terlipressin) for Injection in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at the American College of Gastroenterology (ACG) Annual Meeting
2024-10-26 13:00U:MNKNews ReleaseMallinckrodt Presents Data on TERLIVAZ(TM) (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at Kidney Week 2024
2024-10-24 06:45U:MNKNews ReleaseMallinckrodt to Report Earnings Results for Third Quarter 2024
2024-10-10 06:52U:MNKNews ReleaseMallinckrodt Announces an Expanded Rollout of the INOmax(TM) EVOLVE(TM) DS Delivery System in U.S. Hospitals